3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
7
Plasma cell
6
Classical hematology
2
Thoracic
1
Other hematologic neoplasm
1
Myeloid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Myelodysplastic Syndromes
750
Leukemia, Myeloid, Acute
634
Leukemia
476
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
469
Precursor Cell Lymphoblastic Leukemia-Lymphoma
409
Myeloproliferative Disorders
339
Lymphoma, Non-Hodgkin
271
Leukemia, Myelomonocytic, Chronic
270
Leukemia, Lymphocytic, Chronic, B-Cell
264
Multiple Myeloma
259
Hodgkin Disease
249
Primary Myelofibrosis
230
Leukemia, Myeloid, Chronic-Phase
217
Lymphoma
203
Blast Crisis
194
Leukemia, Myeloid, Accelerated Phase
181
Lymphoma, Mantle-Cell
168
Lymphoma, Follicular
168
Burkitt Lymphoma
166
Lymphoma, Large B-Cell, Diffuse
162
Lymphoma, B-Cell, Marginal Zone
151
Congenital Abnormalities
148
Polycythemia Vera
144
Lymphoma, Large-Cell, Immunoblastic
141
Anemia, Refractory, with Excess of Blasts
131
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
128
Myelodysplastic-Myeloproliferative Diseases
126
Neoplasms, Plasma Cell
117
Thrombocythemia, Essential
114
Lymphoma, T-Cell, Cutaneous
99
Interventions
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hemostatic Disorders
×
Myeloid
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled